Drug Trial Radar · NCT05223907
Safety and Efficacy of Maintenance of Etomidate in General Anesthesia
Last checked: Nov 20, 2026Latest source record: Jun 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,080
Actual
Start
May 1, 2021
Primary completion
Dec 31, 2022
Study completion Dec 31, 2022
Sponsor
- Lead sponsor
- Henan Provincial People's HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 4, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study was designed to use etomidate combined with sevoflurane intravenously to maintain anesthesia process under the monitoring of BIS. Propofol was used as the controls. Blood pressure and heart rate were recorded during operation. The VAS pain score was observed after surgery.To investigate whether this program can better maintain intraoperative hemodynamic stability, improve the quality of recovery, and reduce the incidence of postoperative adverse reactions.
Conditions
- General Anesthesia
Interventions
EtomidateDrug
Etomidate will be used for general anesthesia
PropofolDrug
Propofol will be used for general anesthesia
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of intraoperative hypertension and hypotensionTime frame: From the beginning to the end of surgery
- Ricker sedation-agitation score after surgeryTime frame: 1 day (The period during patients wake up after surgery and general anesthesia in the recovery room.)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Henan Provincial People's Hospital
Zhengzhou, Henan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.